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A research protocol is best viewed as a key to open the gates between the researcher and his/her research objectives. Each 
gate is defended by a gatekeeper whose role is to protect the resources and principles of a domain: the ethics committee 
protects participants and the underlying tenets of good practice, the postgraduate office protects institutional academic 
standards, the health authority protects provincial resources etc. The protocol must explicitly address the issues likely to be 
raised by these gatekeepers, demonstrating evidence of a clear understanding of the issues involved and that all components 
of the research plan have been addressed. The purpose of this paper is to add flesh to the skeleton provided in step six (‘write 
the protocol’) of the Biccard and Rodseth paper of 2014, orientated towards the first-time researcher working towards the 
MMed degree. Although occasional reference will be made to qualitative approaches, it is likely that the majority of these 
studies will be quantitative designs and these form the focus of this paper.
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Introduction
The introduction of compulsory research for medical specialist 
registration with the HPCSA has challenged those institutions 
that historically used the Colleges of Medicine (CMSA) 
examinations as a route to specialisation. Without the resources 
of a fully developed MMed programme (a coursework Masters 
with a practical research component), some departments have 
battled to accommodate the increased workload, especially with 
an inadequate number of experienced research supervisors. 
Students are faced with the tasks of finding a research area of 
interest, identifying and developing a research topic, formulating 
a research question into a suitable protocol, conducting the 
study, analysing the results and writing the paper or dissertation, 
against the background of the demands of clinical training, 
service provision, and preparation for the rigorous examinations 
of the CMSA.
Biccard and Rodseth examined the research process from the 
point of view of the novice researcher and presented a nine-step 
process for taking a research idea to the protocol stage,1 and 
provided an invaluable guide to our students. One of the 
stumbling blocks in the process is the writing of a ‘winning’ 
protocol that passes through postgraduate and ethical review 
with minimum delay and successfully garners research funding. 
A well-written protocol ensures timely approval and smooth 
running of the research process, facilitates subsequent writing of 
the research report, and permits completion within the allotted 
time.
This paper assumes that the student has a clear idea of what 
interests him/her, where the knowledge gap lies (from literature 
review) and has framed either a research question or hypothesis, 
even if not fully developed (steps 1–4, Biccard and Rodseth1). 
Although requirements for protocol format vary between academic 
centres, we have kept largely to the structure recommended by 
Biccard and Rodseth, with slight modification (Table 1).
Introduction and statement of purpose
The introduction is a very brief summary of the literature review 
consisting of a short paragraph identifying the clinical problem, 
outlining the areas of equipoise and previous research 
approaches to them. For example: 
‘Pulmonary aspiration of acid gastric contents has been 
shown to be an important cause of mortality with general 
anaesthesia for caesarean section. Efforts to decrease the 
volume and acidity of gastric contents have included 
reduced oral intake, active pre-operative gastric emptying 
and the use of neutralising antacids, with varying degrees 
of success. One possible method of reducing the incidence 
of acid aspiration might be the preoperative administration 
of a histamine H2 receptor antagonist to reduce gastric 
acid secretion.’
The statement of purpose then outlines exactly what is to be studied 
in the proposed study, how it is to be studied, in whom, where and 
when. Although this normally develops from the subsequent 
background and literature review, it is a useful initial declarative 
statement that crystallises the nature of the study in both the 
reviewer’s and student’s mind and directs the review to relevant 
questions that are best addressed by the student beforehand.
For a quantitative study the format (adapted from Cresswell2) 
would be:
‘The purpose of this … (observational/descriptive, 
comparative, correlational, survival, analytical etc.) study is 
to … (explore, describe, compare etc.) the … (central focus, 
i.e. what you are actually measuring) for/of/in … (population 
sampled) at/in/presenting to … (location) from/ over/ for 
the period … (Dates, time period).’
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Students use this template to create their own purpose 
statements. For example:
‘The purpose of this double blind randomised controlled 
study is to compare the pH and volume of gastric contents 
in term parturients presenting for Caesarean section 
receiving preoperative glopatidine compared to saline 
controls presenting to St Elsewhere’s Hospital for the 
period January to July 2015.’
The importance of this statement is that it creates boundaries in 
addition to providing direction. Any further statement or section of 
the protocol must fall within the limits of purpose; the background/
literature review must demonstrate the research problem and 
equipoise to which this purpose is the natural consequence. The 
direction from the statement naturally leads to specific objectives 
and thence to requisite items within the research instrument (data 
sheet). It also directs the investigator (and reviewer) to pertinent 
statistical and research ethics issues. The combination of purpose 
(represented by aims and objectives) and direction constitutes a 
‘golden thread’ that binds the protocol together.
If a summary of the proposed research is requested in an 
institutional protocol format, grant application form, or ethical 
review application form, this statement is what is required. Do 
not ‘cut and paste’ the opening sentences of the background; this 
is not helpful to the reviewer.
Background and literature review
The function of the background and literature review is to 
encapsulate the clinical problem in such a way that the research 
question or hypothesis naturally emerges.
•  Clinical problem. The background declares and explains 
the clinical problem and summarises existing 
epidemiological, socioeconomic and health systems 
knowledge (etc.) globally (from the world literature), and 
locally (from our regional literature and local audits). In the 
above example, the background would include evidence 
of a problem (for example acid aspiration syndrome) in 
this specific group of patients that is a known cause of 
morbidity or mortality globally and its relevance to local 
circumstances (for example as highlighted by enquiries 
into maternal deaths).
•  The literature review (again starting globally and reducing to 
local experience, i.e. contextualisation) is a critical, objective 
summary of the known extent of the problem and confirms 
that the research question is appropriate. Reference should 
be made to the findings of studies performed internationally 
and locally to address the problem. Novel methods and 
those particularly suited to local circumstances should be 
highlighted. By the end of the review it should be clear that 
the researcher has a thorough understanding of the problem 
and why the proposed study design has been chosen, based 
on gaps in knowledge and conflicting results (equipoise).
 The protocol literature review should be brief but incisive, and 
there may be stipulated requirements (e.g. 500 words, and 5 
references). However, investigators should develop a more 
extensive review, kept as a separate document and repeatedly 
reviewed throughout the study (up to the day of submission 
of the report, in which a more extensive review is required).
•  The research question (or hypothesis) should naturally emerge 
from the background and literature review but must also 
appear as an explicit statement under a separate sub-
heading at the conclusion of this section.
Aims and objectives
Confusion may arise concerning these two terms; semantically 
they are so close as to be virtually indistinguishable and not 
all centres will insist on both. However, we value the 
distinction as it assists in clarifying thought processes within 
the research design.
Aims are what you hope to achieve in your research project and 
objectives are the steps you need to take in order to achieve your 
aims.3 Aims must directly relate to the research question or 
hypothesis. Objectives must relate to the aims. For example:
Research question: What are the risk factors for TB in children 
aged 5–7 years in Limpopo Province?
Aim: To investigate risk factors for TB associated with birthweight, 
socio-demographic factors and pre-school care in Limpopo 
Province
Objectives: To determine the relationships between:
(1)  birthweight and incidence of TB in 5-year-old to 7-year-old 
children;
(2)  day-care facility, type of caregiver and TB;
(3)  socio-demographic factors and TB.
Table 1: Recommended protocol structure
Introduction and statement of purpose
Background to the study
•  Clinical problem
•  Literature review





c. Sampling strategy: Inclusion and exclusion criteria
d. Outcome assessment and measurements
e. Data collection and statistical analysis. Follow-up.
f. Sample size, statistical power and variable selection
Methodological challenges
•  Selection bias
•  Loss to follow-up
Feasibility
•  Recruitment
•  Study team
•  Participating centres
•  Study funding and progress
Study organisation and ensuring data quality
•  Organisation and management
•  Investigator responsibilities
•  Central coordination
•  Ethical considerations
•  Ensuring data quality
Ethical considerations 
Study significance
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Methods
This is the most important section of the protocol. It must convey 
exactly what you are going to do, in whom, where, when, and how. 
Methods must relate directly to and only to the specific objectives 
of the study.
In the above example, recording the birthweight of all 
participants and a history of TB between the ages of 6 and 9 years 
would address objective 1. Testing for HIV status would not 
address any of the objectives as stated, so cannot be included in 
the methodology. Adding this as an ‘afterthought’, before the 
study commences, can only happen if the role of HIV status is 
included in a rewritten background and literature and added as 
an additional objective in the protocol, which would then have 
to be resubmitted. Once the study has commenced, any 
additions or changes cannot be made to the protocol without 
ethical review.
The methods section is written in the future tense. It should be 
written so that anybody can use it to reproduce your study 
exactly (although perhaps with different results). Scrupulous 
adherence to well-written methods enables complete ‘cut and 
paste’ transfer to a report, simply changing future to past tense.
Each of the following must be addressed:
a. Study design. Figure 1 shows a decision tree that can be 
used to categorise types of study as possible research designs. 
Note that there are several different types of observational 
study (case reports, series, prevalence, questionnaires, 
incidence, audit and reviews) and that some of them include 
analytical elements.
N.B. This is not intended to be exhaustive and space does not 
permit detailed descriptions of each design. Readers are 
encouraged to consult more comprehensive sources, such as 
the Lancet epidemiology series by Grimes and Schulz of 2002 
and 2005, the introduction to which4 covers most of the content 
of Figure 1 and provides a brief introduction to the commoner 
designs. The full series is a useful guide to the various research 
designs and includes articles on issues common to all. It is 
available as a Lancet publication.5 The titles of the articles/
chapters have been included as references.6–20 An additional 
reference to stepped wedge designs has been included.21
b. Setting. This states where you will be conducting your 
study, for example a tertiary care dermatology clinic. Remember 
that many research settings (and all that are institutional) will 
require site or gatekeeper permission to conduct your research. 
Have you obtained such? If not, why not? An acceptable reason 
might be ‘Hospital management has been approached, and 
they have deferred approval until provisional Human Research 
Ethics Committee (HREC) approval has been granted’ 
(remember to attach any correspondence as an Appendix 1 to 
your HREC application).
c. Participant selection and sampling strategy. This describes 
whom you are investigating (the population of interest, e.g. all 
people with hypertension), the sampling frame used to access 
the population (e.g. the telephone numbers or postal addresses 
of all people living within a geographical area, or all the patients 
attending a particular clinic) and your sampling strategy (i.e. 
which of the various probabilistic methods or non-probabilistic 
methods will be used), with inclusion and exclusion criteria.
The reviewer will be checking that:
i. the methods used will ensure that the sample (and sampling 
frame) matches the population in which the problem has been 
identified and the research question asked (Representativity). 
Where uneven distributions of a variable are known within a 
population (e.g. disease distributions related to age, gender or 
geographical distribution), a probabilistic (random) sampling 
process should match these via stratified or cluster sampling. In 
non-probabilistic sampling, methods should be used to demonstrate 
avoidance of sampling error by ensuring adequate proportional 
sampling of the known characteristics of the population;
ii. any comparisons of a variable will be made between 
similarly constructed sample groups (Comparability). When 
random allocation is used, sufficient relevant demographic 
data must be recorded to enable subsequent comparability 
testing. With non-probabilistic sampling the protocol must 
document methods used to prevent selection bias;
iii. all relevant social groups are included (Social justice). 
Unless the research problem has been identified as unique to a 
specific social group, all social groups should be included in the 
sampling strategy.
Randomisation and blinding procedures should be included if 
relevant.
The protocol should include a process of handling missing data, 
patients lost to follow-up, and protocol violations. The reviewer 
will be looking for a commitment to an initial intent-to-treat 
analysis using the full data-set and before group identification 
in a double-blind study.
d. Outcome assessment and measurements. Here you provide 
details of what you are going to measure (the outcome 
variables), the methods of measurement to be used and what 
steps you are going to take to avoid measurement error 
(random and systematic error). These details determine the 
internal validity of the study. Remember that what you measure 
must relate to the objectives of the study and may not relate to 
an unstated objective. All outcomes/measurements must be 
clearly defined and the primary outcome identified, which will 
be used for sample size calculations (in large studies secondary 
outcomes may also be used).
e. Data collection and statistical analysis. This must be 
planned in detail. The reviewer will be looking for specific 
information that must be included (Table 2). All outcome 
variables should be in a clear logical format on your data-
collection tool. Statistical analysis is part of the methodology 
and as such misuse, abuse, misapplication and inappropriate 
testing fall within the ethical domain.22 You are likely to require 
statistical advice, either from a professional statistician or an 
experienced, knowledgeable member of your department. Do 
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•  standard deviation (σ, sd) of your variable;
•  your chosen α (probability of accepting a result as a 
statistically significant difference when in reality there is no 
difference);
•  required statistical power (probability that a study will 
detect an effect when there is an effect there to be detected).
These are the estimates the statistician will request in order to 
assist with the calculation.
The control mean may be known (e.g. from previous research, or 
a physiological value such as a systolic pressure of 120 mm Hg), 
and similarly the standard deviation. In which case, the ‘standard’ 
chosen values of α of 0.05 and power of 0.8 might be used (N.B. 
these ‘standard’ values are by convention, not rule; there are 
situations, e.g. differences in mortality, where you would want to 
be more certain and therefore choose a smaller value of α and/or 
a higher power).
Defining an important clinical difference is more of a challenge, 
but it represents your only justifiable method of obtaining a study 
size matched to your resources. Strictly speaking, the important 
clinical difference is the smallest difference that would make you 
change your practice. The most commonly used calculable 
estimate is known as the standardised mean difference (ES):
The difference from your control mean (X1- X2, desired effect size) 
can be altered until the difference divided by the control standard 
deviation represents an appropriate value for the primary 







not use vague statements such as ‘statistical analysis will be 
performed’. Be specific, for example:
‘Descriptive statistics (mean and standard deviation or 
median and interquartile range as appropriate) will be 
used to describe the sample groups. Continuous variable 
group means will be compared using unpaired t-tests for 
normally distributed data, otherwise non-parametric 
(Mann–Whitney U) methods will be used. A p-value 
of < 0.05 will be regarded as statistically significant.’
If relevant (or indeed possible), any planned participant follow-
up should be included at the end of this section and the purpose 
of the follow-up identified. If supplementary data are to be 
sought they should be described here and included on the data 
form to accompany the protocol.
f. Sample size, statistical power and variable selection. 
Statistical advice should be sought. Sample size calculations 
can depend upon circumstances. For example:
1. Sufficient resources (personnel, time, funding and a high 
prevalence or incidence) and an estimate of the mean and 
standard deviation of your outcome variable of main interest 
may be available. In this case you can calculate the required size 
of a comparative study to achieve a given statistical level of 
significance for a predetermined difference of clinical importance 
between means. You will need to have an estimate of:
•  the control mean;
•  an important clinical difference (Δ or effect size, ES);
Figure 1: Decision tree defining research designs, with various examples.
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number of positive outcomes (about 5–10) for each risk factor 
added to the regression. An additional problem with this type of 
study is the confounding effect of two or more related variables 
(e.g. height, weight and body mass index).
Methodological challenges and study 
limitations
This should be a concise, realistic view of the challenges to 
achieving the aims and objectives of the study. It should be long 
enough and detailed enough to demonstrate to the reviewer 
that the study team has insight into what it is doing, but not so 
long and detailed as to suggest that the project has no hope of 
success. Each challenge presented must be accompanied by a 
summary of how the protocol meets the challenge. For example:
•  How have response rates to questionnaires been improved?
•  What efforts have been put in place to select a representative 
sample?
•  Can the results be generalised?
Feasibility
a. Time lines and project management. It must be 
demonstrated that the study can be completed in the time 
available. All stages of the research must be included and time 
allocated to literature search, protocol preparation and realistic 
turnaround time for necessary review following submission, 
recruitment and data collection, data collation and entry into 
electronic format, statistical analysis and review, and finally 
write-up; use of a Gantt chart is recommended. The project 
manager (usually the principal investigator) is responsible for 
ensuring timeous completion of each stage of the project.
b. Study team, contributors and authorship. From the outset it 
should be clear who is responsible for each component of the 
study and who should be acknowledged and who should be an 
author on any papers published from the research. This not 
only clarifies everybody’s role in the project but also avoids 
possible future embarrassment or acrimony. Also, naming 
individuals responsible for each part of the research project can 
ensure that everything gets done. For example, any laboratory 
analysis requires identification of the individual responsible for 
the analysis additional to permission to use the laboratory 
facilities for the project.
A general view of the values of ES might be:
•  ≤ 0.2: a very small effect, of negligible importance;
•  0.5: of moderate importance;
•  0.8: a large difference of considerable importance;
•  ≥ 1: cannot be ignored.
But again, this is context specific. If your primary outcome 
measure is death, an effect size of 0.2 is important, whereas if the 
outcome were a readily treatable decrease in systolic blood 
pressure (say from 120 to 108) then an effect size of 1 might not 
be considered very important.
2. Alternatively, you may have few resources and not know 
the size and range of the variable of interest and wish to describe 
it in a pilot study for future research. You should, however, have 
some idea of how many potential participants you will be able to 
see in the time available (e.g. from a clinic’s records).
In this case, statistical calculations can indicate how accurate your 
estimates of average and range will be. This is important in a 
descriptive study, and explains why protocols containing ‘this is a 
descriptive study only and requires no statistical analysis’ may be 
rejected by reviewers. To underscore this point, Figure 2 depicts 
the upper and lower 95% confidence bounds on a proportion of 
0.1. Assuming a true prevalence of 0.1, if samples of 10 were 
repeatedly taken 95% of these estimates would be found 
between 0.0025 and 0.445, which represent a large range of 
possible answers far removed from the real one. This would not 
represent an adequate sample size for a useful description of an 
outcome measure, in contrast to repeated samples of 200 (95% 
confidence limits 0.062–0.15).
Variables selected for documentation and analysis should be 
kept to the minimum necessary to achieve the aims and 
objectives of the study and answer the research question. Avoid 
the temptation to over-test, either by multiple testing of the 
same variable, or unnecessary testing of additional variables 
(usually in pursuit of critical p-values). Just as buying several 
lottery tickets increases the probability of winning a prize, so 
multiple testing increases the probability of finding an erroneous 
statistically significant difference (type I error). This is a particular 
problem with predictive observational outcome studies when 
too many risk factors are added to a multiple logistic regression 
analysis. If using this type of study design, the reviewer will check 
the anticipated outcome incidence to ensure an appropriate 
Table 2: Statistical treatment: what the reviewer will be looking for (adapted from Bland et al.22)
(1)  The study design and aims must be appropriate to the proposed statistical treatment that will depend upon issues such as randomisation, 
number of groups, whether repeated measures are to be used, possible confounding or interacting factors etc.
(2)  The types of data (continuous, discrete, nominal etc.) to be collected should be specified, to ensure that the proposed statistical analysis is 
appropriate, with clear identification of the outcome variable(s) of main interest on which any power analysis is based
(3)  The number of outcome measures that are to be recorded should be stated, to avoid or adjust for issues of multiple testing
(4)  Any power analysis to estimate required sample sizes for the outcome of interest must be based upon the statistical test identified for use 
in its subsequent evaluation
(5)  The information used in any power analysis (means, proportions, standard deviations, effect size, proposed alpha and power etc.) must be 
included to permit the reviewer to repeat the calculation
(6)  Confirmation that the investigator has the required knowledge to perform the subsequent analysis, or whether assistance will be provided 
by a statistician or person with the necessary expertise
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researchers. Thus scientific content is and always has been within 
the purview of Health Research Ethics Committees. Also the 
underlying principles must be applied to the individual 
participants, so when ‘beneficence’ is discussed it must apply to 
the benefit for the participant in addition to societal value.
Ethical issues arise from (inter alia) the following:
•  direct participant contact (requiring a full explanation of 
what is to be done using simple language and an 
appropriately worded consent document);
•  the inclusion of vulnerable groups (children, prisoners, 
mentally disabled, those in pain);
•  anonymity and confidentiality;
•  data protection and storage;
•  participant reimbursement;
•  insurance against study-related injury;
•  potential risks or discomfort;
•  storage and/or export of tissue samples (including blood);
•  use of health care resources;
•  potential benefits to the patient and society;
•  post-trial access to any demonstrated benefits;
•  the means of dissemination of the results of the study;
•  conflicts of interest.
Remember that research towards a degree is automatically a 
conflict of interests (particularly so when associated with career 
advancement) and should be included in the participant 
information document and consent form. Also research cannot 
proceed without the requisite gatekeeper (site and provincial 
healthcare) permissions.
Study significance
Include a brief concluding paragraph as to the expectations of the 
study in terms of improving knowledge and how the results can be 
applied to the underlying clinical problem addressed by the study.
Example:
‘The significance of this study into the factors underlying 
the pharmacogenetic basis of mitochondrial disorders 
uncovered by HIV infection or initiation of NRTI drugs will 
result in more effective design of NRTI drugs with 
enhanced activity and minimal toxicity, leading to 
improved patient outcome.’
Appendices
These should include your research instrument (i.e. questionnaire 
or data-collection tool), patient information sheet and consent 
form, letters of approval, certificates of ethical and clinical good 
standing and brief curriculum vitae of the principal investigator, 
any co-investigators, supervisors and co-supervisors etc. Ensure 
that all required documentation is included with your protocol 
and HREC submission, using any checklist provided.
Conclusion
Following this format should, it is hoped, result in a smooth 
passage through review committees. The format can be 
converted into a template design that can be used to complete a 
draft protocol within a day, provided that the initial literature 
review and conceptualisation have been completed beforehand.
Regarding authorship, guidelines from the International 
Committee of Medical Journal Editors (ICMJE) should be 
followed.23 Criteria for authorship are:
•  substantial contributions to: the conception or design of the 
work (individual study); OR the acquisition, analysis, OR 
interpretation of data for the work; AND
•  drafting the work or revising it critically for important 
intellectual content (comment during writing the paper); 
AND
•  final approval of the version to be published (email approval 
acceptable); AND
•  agreement to be accountable for all aspects of the work in 
ensuring that questions related to the accuracy or integrity of 
any part of the work are appropriately investigated and resolved.
Contributions not complying with all the criteria merit a detailed 
‘Acknowledgement’ at the end of the paper.
Proposed authorship need not be cast in stone, as required roles 
may change during the course of the study but changes to the 
study personnel may require notification to the Ethics Committee.
c. Participating centres. If the study is to be conducted in 
more than one centre, all centres should have the requisite 
resources (time, personnel, equipment and expertise) to fulfil 
study requirements.
d. Study funding and progress. Protocol submission for a study 
without adequate funding will never bear fruit and is a waste of 
everybody’s time. However, it is acceptable to submit a realistic 
budget with the protocol before a grant has been awarded, as 
most grants will be subject to ethical (and in the case of a degree, 
postgraduate committee) approval, and grant application will 
require your protocol. This section of the protocol must be 
completed even if there are no direct costs (e.g. a historical chart 
review) or the stationery etc. can be covered by departmental 
resources. Costs must match funds. Reasons should be given 
why grants are delayed or deferred if that is the case.
Ethical considerations
While the underlying principles of autonomy, beneficence, non-
maleficence and justice form the basis of research ethics, ethical 
review has to be more extensive. Notably, the participants in the 
study have to be protected from inexpert and unqualified 
Figure 2: 95% confidence limits on a proportion of 0.1 at sample sizes 
from 10 to 200.
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